Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of injectable poly-D,L-lactic acid (PDLLA) for dorsal hand volumization: 8 mL vs 10 mL dilution (Thai subjects, 3‑month evaluation)
TCTR20250519001Phase 3Not yet recruiting
- Sponsor
- K.N.A. Interpharma
- Start
- Jul 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of polylactic acid in dorsal hand volume loss (2 arms), sponsored by K.N.A. Interpharma. Primary endpoint: Primary efficacy at 3 months. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
polylactic acid
03
Conditions
dorsal hand volume loss
Beyond the preview
Go deeper on TCTR20250519001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250519001.